Serum antibodies to cholinergic neurons in Alzheimer's disease
- PMID: 2602432
Serum antibodies to cholinergic neurons in Alzheimer's disease
Abstract
Alzheimer's disease (AD) is associated with degenerative changes in nuclei of the basal forebrain which provide most of the cholinergic innervation of the cortex and hippocampus. Although the etiology and pathogenesis of AD are not known, several reports indicate the involvement of immunological mechanisms. In the present work we examined the existence of antibodies in sera of AD patients which bind specifically to cholinergic neurons. As antigen we employed the purely cholinergic electromotor neurons of the electric fish Torpedo which are chemically homogeneous and cross react antigenically with human and other mammalian cholinergic neurons. Our findings show that immunoglobulins (IgG) from sera of AD patients bind to the heavy neurofilament subunit (NF-H) of these neurons. Comparison of the binding of AD and control IgG to Torpedo cholinergic NF-H revealed that AD IgG bind to this neurofilament protein more than control IgG. In contrast, AD and control IgG bind similarly to NF-H obtained from the chemically heterogeneous Torpedo spinal cord and from rat brain. These findings suggest that AD sera contain a repertoire of anti NF-H IgG and that a subpopulation of these antibodies, whose levels are significantly elevated in AD, binds to epitopes highly enriched in Torpedo cholinergic NF-H. The diagnostic potential of these AD antibodies is discussed.
Similar articles
-
Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons.J Neurosci. 1989 Aug;9(8):2710-7. doi: 10.1523/JNEUROSCI.09-08-02710.1989. J Neurosci. 1989. PMID: 2475591 Free PMC article.
-
Monoclonal antibodies to the heavy neurofilament subunit (NF-H) of Torpedo cholinergic neurons.J Neurosci Res. 1991 Aug;29(4):490-8. doi: 10.1002/jnr.490290409. J Neurosci Res. 1991. PMID: 1791640
-
Antibodies to cholinergic neurons in Alzheimer's disease.J Neurochem. 1988 Aug;51(2):479-85. doi: 10.1111/j.1471-4159.1988.tb01063.x. J Neurochem. 1988. PMID: 3292704
-
Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer's disease.J Neural Transm Suppl. 1997;49:77-84. doi: 10.1007/978-3-7091-6844-8_8. J Neural Transm Suppl. 1997. PMID: 9266416 Review.
-
On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.Crit Rev Immunol. 2001;21(1-3):1-27. Crit Rev Immunol. 2001. PMID: 11642597 Review.
Cited by
-
The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.Mol Neurobiol. 2017 Jan;54(1):623-638. doi: 10.1007/s12035-015-9641-0. Mol Neurobiol. 2017. PMID: 26748510 Review.
-
Studies of neuroimmune markers in Alzheimer's disease.Mol Neurobiol. 1994 Aug-Dec;9(1-3):73-81. doi: 10.1007/BF02816106. Mol Neurobiol. 1994. PMID: 7534089
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials